Glycomimetics (GLYC) Finds a New Pathway to Approval - Roth Capital Jun 15, 2020 06:13AM
GlycoMimetics (GLYC) Defended By Roth, Pathway To Approval Reoppened Says Analyst Jun 12, 2020 03:59PM
Roth Capital Starts Glycomimetics (GLYC) at Buy Nov 13, 2019 05:05PM
GlycoMimetics (GLYC) Prices 7M Share Common Offering at $17/Sh Mar 21, 2018 05:46AM
GlycoMimetics Announces Pricing of Public Offering of Common Stock Mar 20, 2018 09:24PM


Oct 23, 2017 09:14AM Pre-Open Movers 10/23: (AIMT) (PETS) (AGEN) Higher; (DBVT) (ATRS) (GBT) Lower (more...)
Oct 23, 2017 07:32AM UPDATE: Roth Capital Starts Glycomimetics (GLYC) at Buy
Feb 4, 2014 10:44AM Notable Analyst Rating Changes 02/04: (ZNGA) (MRK) (WETF) Upgraded; (HP) (NEM) (TTWO) Downgraded